We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Phenomenex Case Study Documents Cost-Saving API Residual Analysis
Product News

Phenomenex Case Study Documents Cost-Saving API Residual Analysis

Phenomenex Case Study Documents Cost-Saving API Residual Analysis
Product News

Phenomenex Case Study Documents Cost-Saving API Residual Analysis


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Phenomenex Case Study Documents Cost-Saving API Residual Analysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Phenomenex Inc., has announced the publication of a case study, written by scientists at Pfizer, that demonstrates the results of a new method for residual API (active pharmaceutical ingredient) analysis.

This new solution replaces 16 older methods for individual key ingredients, and has delivered cost savings of £320,000 (more than $516,000) per year.

The method requires just one UHPLC instrument, using Phenomenex Kinetex® 1.7-micron core-shell columns, to resolve all 16 ingredients in just six minutes.

In addition to instrument and time savings, the method uses less solvent, reduces waste disposal costs and frees up lab analysts. The method can be reviewed and /or downloaded at: http://www.phenomenex.com/info/form/casestudy.

“High-volume laboratories, such as those in pharmaceutical QC, have an acute need to reduce operating costs and free up resources,” explains Jeremy Bierman, brand manager for HPLC products.

Bierman continued, “The Kinetex core-shell technology allows the development of faster and more efficient analytical methods to deliver significant cost and time savings.”

The Kinetex 1.7-micron column is the first and only sub-2-micron core-shell UHPLC column on the market and typically delivers efficiency gains of 15 to 20 percent over traditional fully porous sub-2-micron columns.

Advertisement